No Data
No Data
Sonnet BioTherapeutics (NASDAQ:SONN) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
Express News | Sonnet Biotherapeutics Holdings Inc - Son-080 Well-Tolerated at Both Doses
Express News | Sonnet Biotherapeutics Reports Encouraging Data From Phase 1B/2a Clinical Trial of Son-080 in Chemotherapy-Induced Peripheral Neuropathy (Cipn) That Support Advancement Into Phase 2 Study
Sonnet Bio Therapeutics Files to Sell 5.77M Shares of Common Stock for Holders
12 Health Care Stocks Moving In Friday's Pre-Market Session
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
No Data